Allohernioplasty with the introduction of platelet-rich plasma (PRP) in a chronic experiment: features of the reparative process

Introduction. Mesh has become the standard for herniorrhaphy – it helps to reduce recurrence and the development of side effects. The regulation of immunocompetent cells migration determines the therapeutic strategy to modulate the inflammatory response.

Aim. To conduct a clinical and morphological analysis of the effect of platelet-rich plasma (PRP) on the course of reparative process in allogernioplasty.

Materials and methods. 47 Wistar rats were divided into 3 groups: with PRP in optimal dosage (n = 15), maximum dosage (n = 15), without PRP (n = 15), two rats were used for terminal blood sampling for PRP manufacturing. All animals were operated on, creating an aponeurosis defect that was closed with a mesh implant followed by PRP application. The severity of postoperative pain syndrome was assessed using the developed by us summary scale of physiological status, behavioral reactions, and facial expressions; the state of the postoperative scar, the terms of postoperative wound hair loss were evaluated. Material for morphologic evaluation was taken on days 7, 14, 21, 28, 60.

Results and discussion. The positive effects of PRP were morphologically confirmed. The biopsy specimens after PRP revealed: absence of rough fibrosis, more abundant vascularization, early formation of a “delicate” scar and lymphatic collectors in the peri-implant zone, absence or minimal expression of degenerative changes of nerve trunks. There is a reduction of the alteration phase and acceleration of repair processes. In animals of group PRP overdose in the postoperative period a pronounced destructive-inflammatory reaction with microbial contamination prevailed, up to the formation of chronic abscesses. We attribute these changes to excessive recruitment of neutrophils and macrophages secreting proteases and proinflammatory cytokines.

Conclusion. The use of PRP in the optimal dosage allows to improve the integration of the mesh implant during allogerniopalasty, prevents rough fibrosis, deformation and shriveling of the implant; reduces the probability of chronic pain syndrome development.

1. International guidelines for groin hernia management. Hernia. 2018;22(2):1–165. https://doi.org/10.1007/s10029-017-1668-x.

2. Lomanto D, Cheach JM, Faylona JM, Huang CS, Lohsiriwat D, Maleachi A et al. Inguinal hernia repair: toward Asian guideline. Asian J Endosc Surg. 2015;8(1):16–23. https://doi.org/10.1111/ases.12141.

3. Bosanquet DC, Ansell J, Abdelrahman T, Cornish J, Harries R, Stimpson A et al. Systematic review and meta-regression of factors afecting midline incisional hernia rates: analysis of 14.618 Patients. PLoS ONE. 2015;10(9):e0138745. https://doi.org/10.1371/journal.pone.0138745.

4. Fink C, Baumann P, Wente MN, Knebel P, Bruckner T, Ulrich A et al. Incisional hernia rate 3 years after midline laparotomy. Br J Surg. 2014;101(2):51–54. https://doi.org/10.1002/bjs.9364.

5. Itatsu K, Yokoyama Y, Sugawara G, Kubota H, Tojima Y, Kurumiya Y et al. Incidence of and risk factors for incisional hernia after abdominal surgery. Br J Surg. 2014;101(2):1439–1447. https://doi.org/10.1002/bjs.9600.

6. Акимов ВП, Чургулиа МЗ, Крикунов ДЮ. Методика интраабдоминального расположения сетчатых имплантов как вариант хирургического лечения вентральных грыж. В: Проблемы и перспективы в международном трансфере инновационных технологий: сборник статей по итогам Международной научно-практической конференции. Пермь, 12 февраля 2018 г. Стерлитамак: АМИ; 2018. С. 18–20. Режим доступа: https://ami.im/sbornik/MNPK-181.pdf.

7. Ivanov YV, Terekhin AA, Shablovsky OR, Panchenkov DN. Allohernioplasty Laparoscopic Postoperative Ventral Hernias. Journal of Experimental and Clinical Surgery. 2017;10(1):10–20. (In Russ.) https://doi.org/10.18499/2070-478X-2017-10-1-10-20.

8. Patiniott P, Stagg B, Karatassas A, Maddern G. Developing a Hernia Mesh Tissue Integration Index Using a Porcine Model – a Pilot Study. Front Surgery. 2020;7:600195. https://doi.org/10.3389/fsurg.2020.600195.

9. Pande T, Naidu CS. Mesh infection in cases of polypropylene mesh hernioplasty. Hernia. 2020;24(4):849–856. https://doi.org/10.1007/s10029-020-02142-5.

10. Nurden AТ. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(Suppl. 1):S13–S33. https://doi.org/10.1160/ths10-11-0720.

11. Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 2005;15(11):599–607. https://doi.org/10.1016/j.tcb.2005.09.002.

12. Medvedev VL, Kogan MI, Mihailov IV, Lepetunov SN. Platelet-rich autologous plasma: what is it and for what? Vestnik Urologii. 2020;8(2):67–77. (In Russ.) https://doi.org/10.21886/2308-6424-2020-8-2-67-77.

13. Krupina EA. Molecular and Biological аspects of Platelet-Rich Plasma Therapies. Bulletin of Pirogov National Medical & Surgical Center. 2020;15(3):80–85. (In Russ.) https://doi.org./10.25881/BPNMSC.2020.30.34.015.

14. Lipatov VA, Severinov DA, Kryukov AA, Sahakyan AR. Ethical and legal aspects of in vivo experimental biomedical research of the conduct. Part II. I.P. Pavlov Russian Medical Biological Herald. 2019;27(2):245–257. (In Russ.) https://doi.org/10.23888/PAVLOVJ2019272245-257.

15. Pain and distress in laboratory rodents and lagomorphs: Report of the Federation of European Laboratory Animal Science Associations (FELASA) Working Group on Pain and Distress accepted by the FELASA Board of Management November 1992. Lab Anim. 1994;28(2):97–112. https://doi.org/10.1258/002367794780745308.

16. Karamyan AS. Recognition of pain and stress in laboratory animals. International Research Journal. 2022;118(4):140–142. (In Russ.) https://doi.org/10.23670/IRJ.2022.118.4.021.

17. Burkholder T, Foltz C, Karlsson E, Linton CG, Smith JM. Health Evaluation of Experimental Laboratory Mice. Curr Protoc Mouse Biol. 2012;2:145–165. https://doi.org/10.1002/9780470942390.mo110217.

18. Nikolidakis D, Jansen J. The biology of platelet-rich plasma and its application in oralsurgery: Literature Reviev. Tissue Eng Part B Rev. 2008;14(3):249–258. https://doi.org/10.1089/ten.teb.2008.0062.

19. Fernandez-Moure JS, Van Eps JL, Scherba JC, Yazdi IK, Robbins A, Cabrera F et al. Addition of platelet-rich plasma supports immune modulation and improved mechanical integrity in Alloderm mesh for ventral hernia repair in a rat model. J Tissue Eng Regen Med. 2021;15(1):3–13. https://doi.org/10.1002/term.3156.

20. Van Eps J, Fernandez-Moure J, Cabrera F, Wang X, Karim A, Corradetti B et al. Decreased hernia recurrence using autologous platelet-rich plasma (PRP) with Strattice™ mesh in a rodent ventral hernia model. Surg Endosc. 2016;30(8):3239–3249. https://doi.org/10.1007/s00464-015-4645-4.

21. Bande D, Moltó L, Pereira JA, Montes A. Chronic pain after groin hernia repair: pain characteristics and impact on quality of life. BMC Surg. 2020;20(1):147. https://doi.org/10.1186/s12893-020-00805-9.

22. Gram-Hanssen A, Öberg S, Rosenberg J. A Critical Appraisal of the Chronic Pain Rate After Inguinal Hernia Repair. J Abdom Wall Surg. 2023;2:10972. https://doi.org/10.3389/jaws.2023.10972.

23. Andia I, Sanchez M, Maffulli N. Basic science: Molecular and Biological aspects of Platelet-Rich Plasma Therapies. Oper Tech Orthop. 2012:22(2):3–9. https://doi.org/10.1053/j.oto.2011.09.005.